What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Psychiatry
Chaim G. Pick mostly deals with Traumatic brain injury, Internal medicine, Pharmacology, Endocrinology and Neuroscience.
The study incorporates disciplines such as Tumor necrosis factor alpha, Cytokine, Young adult, Neuroprotection and Hippocampus in addition to Traumatic brain injury.
His Internal medicine research incorporates themes from Developmental psychology and Acute pain.
His Pharmacology research is multidisciplinary, incorporating elements of Agonist, Ratón, Opioid and Nociception.
His Endocrinology study combines topics in areas such as Glycogen synthase and GSK-3.
His Neuroscience study combines topics in areas such as Head trauma and Pathophysiology.
His most cited work include:
- Environmental enrichment in mice decreases anxiety, attenuates stress responses and enhances natural killer cell activity. (321 citations)
- Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. (249 citations)
- Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus (246 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Traumatic brain injury, Internal medicine, Endocrinology, Pharmacology and Neuroscience.
His studies deal with areas such as Anesthesia, Head injury, Cognition, Neuroprotection and Pathology as well as Traumatic brain injury.
The study of Internal medicine is intertwined with the study of Immunology in a number of ways.
Hippocampus, Hippocampal formation, Central nervous system, Cholinergic and Phenobarbital are the primary areas of interest in his Endocrinology study.
His study looks at the relationship between Pharmacology and topics such as Opioid, which overlap with Nociception.
The study incorporates disciplines such as Pathophysiology and Disease in addition to Neuroscience.
He most often published in these fields:
- Traumatic brain injury (36.61%)
- Internal medicine (35.27%)
- Endocrinology (33.93%)
What were the highlights of his more recent work (between 2016-2021)?
- Traumatic brain injury (36.61%)
- Neuroscience (18.75%)
- Internal medicine (35.27%)
In recent papers he was focusing on the following fields of study:
Traumatic brain injury, Neuroscience, Internal medicine, Neuroprotection and Endocrinology are his primary areas of study.
His Traumatic brain injury research includes elements of Anesthesia, Inflammation, Cognition, Disease and Hippocampus.
The concepts of his Hippocampus study are interwoven with issues in Closed head injury and Pathological.
His research on Neuroprotection concerns the broader Pharmacology.
Chaim G. Pick has researched Pharmacology in several fields, including Behavioural despair test, Opioid receptor, Opioid, PB-22 and AB-CHMINACA.
His studies in Endocrinology integrate themes in fields like Anandamide, Cannabinoid receptor and Glucagon-like peptide 1 receptor.
Between 2016 and 2021, his most popular works were:
- Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injury. (25 citations)
- Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degeneration. (22 citations)
- Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine (21 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Disease
His main research concerns Traumatic brain injury, Neuroprotection, Neuroscience, Internal medicine and Endocrinology.
His research in Traumatic brain injury intersects with topics in Anesthesia, Surgery, Physical therapy and Cognitive test.
His Surgery research is multidisciplinary, relying on both Hippocampus, Programmed cell death and Pathology.
His Neuroprotection research is multidisciplinary, incorporating elements of Pharmacokinetics, Multiple sclerosis, Central nervous system and Atrophy.
The various areas that Chaim G. Pick examines in his Neuroscience study include -Naloxone, Pathophysiology and Endogenous opioid.
Neurodegeneration, Agonist, Opioid receptor and Opioid are among the areas of Internal medicine where Chaim G. Pick concentrates his study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
